Skip to main content
Clinical Trials/NCT00916435
NCT00916435
Completed
Not Applicable

Prospective Observational Study of the ICD Intracardiac Electrograms for Prediction of Ventricular Tachyarrhythmias and Congestive Heart Failure

Johns Hopkins University2 sites in 1 country630 target enrollmentMarch 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Congestive Heart Failure
Sponsor
Johns Hopkins University
Enrollment
630
Locations
2
Primary Endpoint
sustained ventricular tachycardia with appropriate ICD therapies (either shock or ATP)
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

The purpose of this study is to determine whether waveforms of the intracardiac electrograms, acquired through an ICD, can be used:

  • to predict malignant ventricular arrhythmias, requiring appropriate ICD therapies, and
  • to predict progression of heart failure in patients with ICD.
Registry
clinicaltrials.gov
Start Date
March 2005
End Date
December 2011
Last Updated
11 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Larisa Tereshchenko

Instructor of Medicine

Johns Hopkins University

Eligibility Criteria

Inclusion Criteria

  • history of acute MI at least 4 weeks old
  • non-ischemic LV dysfunction for at least 9 months
  • who have an EF \< or = to 35%
  • who was resuscitated from sudden cardiac arrest (ventricular tachyarrhythmia)
  • undergone implantation of an FDA-approved ICD for primary or secondary prevention of SCD

Exclusion Criteria

  • inability or unwillingness to provide valid informed consent
  • pregnancy
  • any condition other than cardiac disease that was associated with a high likelihood of death during 1 year after enrollment

Outcomes

Primary Outcomes

sustained ventricular tachycardia with appropriate ICD therapies (either shock or ATP)

Time Frame: from enrollment up to 72 months

Secondary Outcomes

  • Composite heart failure outcome (HF hospitalization, HF death, heart transplant)(from enrollment up to 72 months)
  • All-cause mortality(from enrollment up to 72 months)

Study Sites (2)

Loading locations...

Similar Trials